Fludarabine and Exposure-Targeted Busulfan Compares Favorably with Busulfan/Cyclophosphamide-Based Regimens in Pediatric Hematopoietic Cell Transplantation: Maintaining Efficacy with Less Toxicity
Imke H. Bartelink(University of California, San Francisco), Jaap Jan Boelens(Wilhelmina Children's Hospital), Elisabeth M L van Reij(University Medical Center Utrecht), Erik M. van Maarseveen(Utrecht University), Caroline A. Lindemans(University Medical Center Utrecht), Birgitta Versluys(University Medical Center Utrecht), Marc Bierings(University Medical Center Utrecht), Arianne de Wildt(University Medical Center Utrecht), Corinne Gerhardt(University Medical Center Utrecht)
Cited by 110
Related Papers
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
|The Lancet|2012|376
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
|Journal of Clinical Oncology|2020|333